Skip to content

Insider · CIK 0001714563

Aoife Brennan

ceopresidentofficerdirector

Files at CLYM (Climb Bio, Inc.), XLO (Xilio Therapeutics, Inc.). First filing Jul 1, 2025, latest Jul 1, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $25k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

CLYM: Climb Bio, Inc.

CLYMOct 9, 2026 · close 11.00

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
13Weak
CLYMsell 210b5-1
Climb Bio, Inc.
$25k
20,618 shares
-30%+10% from low-85% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jan 6, 2026CLYM
Climb Bio, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+700,000$0.00$0700,000Jan 8, 2026
Jun 27, 2025CLYM
Climb Bio, Inc.
MOption exercise
Common Stock10b5-1
+68,750--68,750Jul 1, 2025
Jun 30, 2025CLYM
Climb Bio, Inc.
SOpen-market sale
Common Stock10b5-1
-20,618$1.22$25k48,132Jul 1, 2025
Jun 27, 2025CLYM
Climb Bio, Inc.
MOption exercise
Restricted Stock Unitsderivative10b5-1
-68,750$0.00$0206,250Jul 1, 2025
Jun 11, 2025XLO
Xilio Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+31,000$0.00$031,000Jun 12, 2025
Jan 13, 2025CLYM
Climb Bio, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+1,150,000$0.00$01,150,000Jan 15, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Aoife Brennan: insider trades and track record | InsiderTell